Dr. Megan Levings is a Professor in the Department of Surgery and School of Biomedical Engineering at the University of British Columbia and BC Children’s Hospital Research Institute. Her lab studies how a special kind of white blood cell, known as a T regulatory cell, could be used as a cellular therapy to stop harmful immune responses. She is internationally recognized in the field of human immunology. She leads a vibrant group of trainees and staff who are researching how to use T regulatory cells to replace conventional immunosuppression in the context of transplantation and autoimmunity. She has won numerous awards, including the 2020 YWCA Woman of Distinction, Science, Research & Technology, the 2022 Simon Fraser University Outstanding Alumni Award, and the 2022 UBC Faculty of Medicine Distinguished Researcher in the Basic/Foundational Science Category.